New platform tests AI fairness and accuracy in diabetic eye disease screening

Researchers have developed the world’s first real-world head-to-head testing platform to determine whether commercial artificial intelligence (AI) algorithms are fit for NHS use to detect disease in a fair, equitable, transparent and trustworthy…

Continue Reading

News Source: medicalxpress.com